Ovid Historical Cash Flow
| OVID Stock | USD 1.05 0.01 0.94% |
Analysis of Ovid Therapeutics cash flow over time is an excellent tool to project Ovid Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 1.7 M or Capital Expenditures of 130.6 K as it is a great indicator of Ovid Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Ovid Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ovid Therapeutics is a good buy for the upcoming year.
Ovid |
About Ovid Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Ovid balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Ovid's non-liquid assets can be easily converted into cash.
Ovid Therapeutics Cash Flow Chart
Add Fundamental
Depreciation
Depreciation indicates how much of Ovid Therapeutics value has been used up. For tax purposes Ovid Therapeutics can deduct the cost of the tangible assets it purchases as business expenses. However, Ovid Therapeutics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by Ovid Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Ovid Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Ovid Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Ovid Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ovid Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.At present, Ovid Therapeutics' Depreciation is projected to increase significantly based on the last few years of reporting. The current year's Change To Netincome is expected to grow to about 8.9 M, whereas Change In Cash is projected to grow to (16.9 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 189.4K | 1.4M | 137.5K | 130.6K | Depreciation | 237.1K | 1.4M | 1.6M | 1.7M |
Ovid Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Ovid Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ovid Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 64.3M | 47.1M | 904.1K | 180.7K | 162.6K | 154.5K | |
| Change In Cash | 5.4M | 30.1M | 117.7M | (142.9M) | (17.8M) | (16.9M) | |
| Total Cashflows From Investing Activities | (30.0M) | 34.6M | (1.8M) | (87.9M) | (79.1M) | (75.1M) | |
| Other Cashflows From Financing Activities | 131.9K | 341.0K | 904.1K | 180.7K | 30.5M | 32.1M | |
| Depreciation | 255.0K | 306.8K | 237.1K | 1.4M | 1.6M | 1.7M | |
| Capital Expenditures | 244.0K | 390.7K | 189.4K | 1.4M | 137.5K | 130.6K | |
| Total Cash From Operating Activities | (51.1M) | (51.6M) | 118.6M | (55.2M) | (45.8M) | (43.5M) | |
| Change To Operating Activities | 4.6M | 7.1M | (6.1M) | (3.1M) | (2.8M) | (2.6M) | |
| Net Income | (60.5M) | (81.0M) | 122.8M | (54.2M) | (52.3M) | (49.7M) | |
| Total Cash From Financing Activities | 86.5M | 47.1M | 904.1K | 180.7K | 30.5M | 24.8M | |
| End Period Cash Flow | 41.9M | 72.0M | 189.7M | 46.8M | 27.0M | 25.7M | |
| Change To Netincome | 5.2M | 7.3M | 5.1M | 6.6M | 7.5M | 8.9M | |
| Change To Liabilities | 1.8M | 14.7M | (17.5M) | (8.3M) | (7.5M) | (7.1M) | |
| Investments | (29.8M) | 35.0M | (1.6M) | (85.5M) | 41.8M | 43.9M | |
| Stock Based Compensation | 5.2M | 7.5M | 5.1M | 6.6M | 7.3M | 6.1M | |
| Free Cash Flow | (51.3M) | (52.0M) | 118.4M | (56.6M) | (45.9M) | (48.2M) | |
| Change In Working Capital | 3.9M | 21.8M | (16.8M) | (8.2M) | 2.4M | 2.5M | |
| Begin Period Cash Flow | 36.5M | 41.9M | 72.0M | 189.7M | 44.9M | 73.2M | |
| Other Non Cash Items | (29.6K) | (199.4K) | 7.3M | (764.9K) | (4.7M) | (4.5M) | |
| Other Cashflows From Investing Activities | (186.9K) | (263.4K) | (5.4K) | (1.2M) | (1.1M) | (1.1M) | |
| Cash And Cash Equivalents Changes | 5.4M | 30.1M | 117.7M | (142.9M) | (128.6M) | (122.2M) | |
| Cash Flows Other Operating | 2.6M | (1.1M) | 6.9M | 213.5K | 192.1K | 182.5K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ovid Therapeutics is a strong investment it is important to analyze Ovid Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ovid Therapeutics' future performance. For an informed investment choice regarding Ovid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ovid Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ovid Therapeutics. If investors know Ovid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ovid Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.009 | Quarterly Revenue Growth 0.587 | Return On Assets (0.36) | Return On Equity (0.37) |
The market value of Ovid Therapeutics is measured differently than its book value, which is the value of Ovid that is recorded on the company's balance sheet. Investors also form their own opinion of Ovid Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Ovid Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ovid Therapeutics' market value can be influenced by many factors that don't directly affect Ovid Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ovid Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ovid Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ovid Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.